Modified MMAF structure
|
Common Name | Modified MMAF | ||
|---|---|---|---|---|
| CAS Number | 1352202-47-1 | Molecular Weight | 840.10 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C45H73N7O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Modified MMAFModified MMAF, an ADC cytotoxin, can be used in the synthesis of Antibody-drug Conjugate (ADC). Modified MMAF can be used for the targeted treatment of cancer[1]. |
| Name | Modified MMAF |
|---|
| Description | Modified MMAF, an ADC cytotoxin, can be used in the synthesis of Antibody-drug Conjugate (ADC). Modified MMAF can be used for the targeted treatment of cancer[1]. |
|---|---|
| Related Catalog | |
| In Vitro | MMAF inhibits anaplastic large cell lymphoma Karpas 299, breast carcinoma H3396, renal cell carcinoma 786-O and Caki-1 cells with IC50s of 119, 105, 257 and 200 nM in vitro cytotoxicity assay[2]. |
| References |
| Molecular Formula | C45H73N7O8 |
|---|---|
| Molecular Weight | 840.10 |